Education and debate
Updated New Zealand cardiovascular disease risk-benefit prediction guide
Cite this as:
BMJ
2000;320:709
- Drugs: cardiovascular system
- Hypertension
- Health education
- Health promotion
- Pacing and electrophysiology
- Smoking
- Smoking and tobacco
- Stroke
- Heart failure
- Ischaemic heart disease
- Cardiothoracic surgery
- Clinical diagnostic tests
- Diabetes
- Diet
- Echocardiography
- Metabolic disorders
- Proteinurea
- Radiology
- Radiology (diagnostics)
- Urological surgery
- Urology
- Vascular surgery
- Obesity (nutrition)
- Obesity (public health)
More topics 
Fewer topics
- Rodney Jackson, professor of epidemiology (rt.jackson@auckland.ac.nz)
- Department of Community Health, University of Auckland, Auckland, New Zealand
Editorial by Jackson
The benefits of drug treatment for patients with raised blood pressure or blood cholesterol are directly related to their pretreatment risk of a cardiovascular disease event.1 2 This guide provides a simple quantitative method for assessing a person's risk of cardiovascular disease and the likely benefits of lowering blood pressure or blood cholesterol with drugs. These instructions and charts (figure) combine and update previous New Zealand cardiovascular disease risk assessment charts.3 4 This is not a guideline for managing cardiovascular disease risk.
Assessing risk of a cardiovascular event over next five years
A cardiovascular event is defined as a death related to coronary disease, non-fatal myocardial infarction, new angina, fatal or non-fatal stroke or transient ischaemic attack, or the development of congestive heart failure or peripheral vascular disease.
Estimating risk of cardiovascular disease
In …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Social bookmarking